Cemal Nuri Erçin

1.2k total citations
37 papers, 885 citations indexed

About

Cemal Nuri Erçin is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Cemal Nuri Erçin has authored 37 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Cardiology and Cardiovascular Medicine and 12 papers in Surgery. Recurrent topics in Cemal Nuri Erçin's work include Liver Disease Diagnosis and Treatment (14 papers), Lipid metabolism and disorders (8 papers) and Cardiovascular Disease and Adiposity (5 papers). Cemal Nuri Erçin is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Lipid metabolism and disorders (8 papers) and Cardiovascular Disease and Adiposity (5 papers). Cemal Nuri Erçin collaborates with scholars based in Türkiye, United States and Italy. Cemal Nuri Erçin's co-authors include Teoman Doğru, Serkan Tapan, Halil Genç, Sait Bağcı, Muammer Kara, M. Erbil, Alper Sönmez, Yıldırım Karslıoğlu, Erdim Sertoğlu and Gürkan Çelebi and has published in prestigious journals such as Journal of Hepatology, Metabolism and Clinical Endocrinology.

In The Last Decade

Cemal Nuri Erçin

35 papers receiving 869 citations

Peers

Cemal Nuri Erçin
Teoman Doğru Türkiye
Cemal Nuri Erçin
Citations per year, relative to Cemal Nuri Erçin Cemal Nuri Erçin (= 1×) peers Teoman Doğru

Countries citing papers authored by Cemal Nuri Erçin

Since Specialization
Citations

This map shows the geographic impact of Cemal Nuri Erçin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cemal Nuri Erçin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cemal Nuri Erçin more than expected).

Fields of papers citing papers by Cemal Nuri Erçin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cemal Nuri Erçin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cemal Nuri Erçin. The network helps show where Cemal Nuri Erçin may publish in the future.

Co-authorship network of co-authors of Cemal Nuri Erçin

This figure shows the co-authorship network connecting the top 25 collaborators of Cemal Nuri Erçin. A scholar is included among the top collaborators of Cemal Nuri Erçin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cemal Nuri Erçin. Cemal Nuri Erçin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gündoğmuş, İbrahi̇m, Mehmet Sinan Aydın, Bülent Çelik, et al.. (2021). Is the choice of anesthesia during gastrointestinal endoscopic procedures a result of anxiety?. Arab Journal of Gastroenterology. 22(1). 56–60. 4 indexed citations
2.
Kabaçam, Gökhan, Murat Dayangaç, Enver Uçbılek, et al.. (2020). The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. The Turkish Journal of Gastroenterology. 31(5). 348–355. 3 indexed citations
4.
Karaman, Bülent, et al.. (2017). Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience. Journal of Gastrointestinal Cancer. 48(3). 281–281. 1 indexed citations
5.
Genç, Halil, et al.. (2016). Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease.. PubMed. 20(20). 4305–4312. 19 indexed citations
6.
Erçin, Cemal Nuri, Teoman Doğru, Gürkan Çelebi, et al.. (2016). The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease. TURKISH JOURNAL OF MEDICAL SCIENCES. 46(4). 985–991. 8 indexed citations
7.
Erçin, Cemal Nuri, Teoman Doğru, Halil Genç, et al.. (2015). Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders. 13(7). 319–325. 33 indexed citations
8.
Doğru, Teoman, Halil Genç, Serkan Tapan, et al.. (2011). Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?. Diabetes Research and Clinical Practice. 96(1). 47–52. 39 indexed citations
9.
Genç, Halil, Teoman Doğru, Serkan Tapan, et al.. (2011). Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Scandinavian Journal of Gastroenterology. 46(11). 1355–1361. 16 indexed citations
10.
Tapan, Serkan, Teoman Doğru, Muammer Kara, et al.. (2010). Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Clinical and Laboratory Investigation. 70(6). 399–403. 12 indexed citations
11.
Kılcıler, Güldem, Halil Genç, Serkan Tapan, et al.. (2010). Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Upsala Journal of Medical Sciences. 115(4). 253–259. 52 indexed citations
12.
Tapan, Serkan, Nuri Karadurmuş, Teoman Doğru, et al.. (2010). Decreased small dense LDL levels in Gilbert's syndrome. Clinical Biochemistry. 44(4). 300–303. 34 indexed citations
13.
Sönmez, Alper, Gürkan Çelebi, Gökhan Erdem, et al.. (2010). Plasma Apelin and ADMA Levels in Patients with Essential Hypertension. Clinical and Experimental Hypertension. 32(3). 179–183. 79 indexed citations
14.
Tapan, Serkan, Teoman Doğru, İlker Taşçı, et al.. (2009). Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?. Clinical Biochemistry. 42(9). 791–795. 27 indexed citations
15.
Erçin, Cemal Nuri, Teoman Doğru, Serkan Tapan, et al.. (2009). Levels of Soluble CD40 Ligand and P-Selectin in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 55(4). 1128–1134. 12 indexed citations
16.
Kantarcıoğlu, Murat, Güldem Kılcıler, İlker Turan, et al.. (2009). Solitary Peutz–Jeghers-type hamartomatous polyp as a cause of recurrent acute pancreatitis. Endoscopy. 41(S 02). E117–E118. 5 indexed citations
17.
Erdem, Gökhan, Halil Genç, Serkan Tapan, et al.. (2008). Circulating von Willebrand Factor Levels in Patients with Prediabetes. Turkiye Klinikleri Tip Bilimleri Dergisi. 28(6). 822–827. 1 indexed citations
18.
Yeşilova, Zeki, Muhittin A. Serdar, Cemal Nuri Erçin, et al.. (2008). Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome. Journal of Gastroenterology and Hepatology. 23(10). 1556–1560. 38 indexed citations
19.
Erdem, Gökhan, Teoman Doğru, İlker Taşçı, et al.. (2008). The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 82(2). 214–218. 24 indexed citations
20.
Erçin, Cemal Nuri, Zeki Yeşilova, Ahmet Korkmaz, et al.. (2008). The Effect of iNOS Inhibitors and Hyperbaric Oxygen Treatment in a Rat Model of Experimental Colitis. Digestive Diseases and Sciences. 54(1). 75–79. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026